Study Proposes mRNA Vaccine Spike Protein Production Can Be Deactivated and Turned ‘Off’
The McCullough Foundation published a new study that proposes an intervention to turn off the mutagenic effects of COVID mRNA injections by using small interfering RNA (siRNA) to bind to COVID vaccine mRNA so that the body may eliminate it, and ribonuclease targeting chimeras (RIBOTAC) that can sandwich the mRNA. The introduction of siRNA and RIBOTAC may potentially prevent uncontrolled Spike protein production and reduce toxicity. The targeted nature of siRNA and RIBOTACs allows for precise intervention to inactivate and degrade residual vaccine mRNA, offering a path to prevent and mitigate adverse events of mRNA-based therapies. Dr. McCullough said that some siRNAs [pitirosan and incleanseran] are already used in practice and that he hopes that a biological technology company will produce RIBOTAC.
Dr. McCullough recommends his Base Spike Protein Detoxification protocol that includes nattokinase, bromelin, and curcumin that are available at the Wellness Company He said that nattokinase dissolves blood clots and gave dosages in the video.
mRNA from the jabs has been shown to circulate in the blood for at least 28 days and can be stuck in lymph nodes for at least two months. Spike proteins are said to be circulating at high levels, based on antibodies against the spike protein.
Moderna has had several more mRNA ‘vaccines’, including one for the flu, approved. More mRNA injections will make people more progressively sick because it is synthetic and resistant to the body breaking it down naturally.
.
A preprint study coauthored by Dr. Peter McCullough, published in May, described a novel method of deactivating the genetic alteration effects of the mRNA Covid vaccinations, providing hope to the billions of people who’ve been genetically mutated.
“The Pfizer-BioNTech and Moderna biodistribution studies refute the assertion that nanolipid-bound nms-mRNA remains in the deltoid muscle or axillary lymph nodes. Detectable vaccine mRNA levels remaining in various tissues raises potential safety concerns,” the study said in the ‘Conclusions’ section. “The possibility of vaccine mRNA integration into the host genome and the prospect of unintended protein production due to read through advocate for a mechanism to eliminate lingering synthetic mRNA and halt damaging Spike protein production. The use of siRNA and RIBOTACs to target and degrade vaccine mRNA are promising approaches to mitigate deleterious health effects. The ability to readily tailor the siRNA and RIBOTACs to target an mRNA of interest makes these techniques particularly appealing, although further investigation is warranted to address challenges which include possible off-target effects and immune system activation.”
Messenger RNA (mRNA) technology, referred to in Moderna’s patents as modified mRNA or mmRNA for modified messenger RNA, is an exotic technology that encapsulates an altered RNA sequence within a lipid nanoparticle so as to introduce it into the cells of the vaccinated individual. The foreign man-made sequence is then incorporated into the cells of the vaccinated individual, thus acting more as a gene therapy than a traditional vaccine.
While the exotic injection makes the individual begin to produce the dangerous Covid spike protein, currently there is no way to stop the individual from producing that spike protein forever. There is no ‘off’ switch, at least until now.
The study described a method of turning off the production of the spike protein.
“…the longevity of the encapsulated mRNA along with unlimited production of the damaging and potentially lethal Spike (S) protein call for strategies to mitigate potential adverse effects,” the study said in the ‘Abstract’ section. “Here, we explore the potential of small interfering RNA (siRNA) and ribonuclease targeting chimeras (RIBOTACs) as promising solutions to target, inactivate, and degrade residual and persistent vaccine mRNA, thereby potentially preventing uncontrolled Spike protein production and reducing toxicity. The targeted nature of siRNA and RIBOTACs allows for precise intervention, offering a path to prevent and mitigate adverse events of mRNA-based therapies.”
Link for Study by Nicolas Hulscher, Dr. McCullough, and Diane E. Marotta: https://osf.io/preprints/osf/qxbgu
from: https://needtoknow.news/2024/06/study-proposes-mrna-vaccine-spike-protein-production-can-be-deactivated-and-turned-off/